GenCanna · 16 hours ago
GUMMY FORMULATOR CONSULTANT
GenCanna is seeking an experienced Gummy Formulator Consultant to support select, project-based formulation and commercialization initiatives. The consultant will provide technical and formulation expertise across early-stage opportunity assessment through commercialization support.
AgricultureFarmingHealth Care
Responsibilities
Provide technical feasibility assessments of Sales-proposed gummy product opportunities (ingredients, claims, manufacturability, risk)
Develop bench-top gummy formulations and samples for approved projects
Collaborate with Formulations and Sales teams as needed to align technical feasibility with commercial objectives
At GenCanna’s request—and at GenCanna’s expense—support commercialization and scale-up activities, including pilot runs, process troubleshooting, and manufacturing readiness
Qualification
Required
Demonstrated experience formulating gummy dosage forms (pectin and/or gelatin; sugar and sugar-free preferred)
Hands-on experience with vitamin, mineral, and botanical systems
Strong understanding of dietary supplement regulatory and cGMP manufacturing environments
Ability to translate commercial concepts into practical, scalable formulations
Comfortable working cross-functionally with R&D, Operations, Quality, and Sales
Preferred
Formulation of challenging actives, including minerals, amino acids, botanical extracts, and high-dose vitamin systems
Experience with taste-masking strategies for bitter or metallic actives
Knowledge of gummy coatings and finishing, including oil-based, wax-based, sugar, and non-sugar systems
Experience addressing water activity, moisture migration, and texture stability over shelf life
Familiarity with stability testing, accelerated aging, and shelf-life prediction for gummies
Understanding of packaging interactions and their impact on gummy stability and appearance
Company
GenCanna
GenCanna is a comapny that has assembled top-quality genetics for cultivating hemp.
Funding
Current Stage
Growth StageTotal Funding
$30MKey Investors
MariMed
2018-11-12Corporate Round· $30M
Recent News
2024-11-15
Canada NewsWire
2024-01-27
Company data provided by crunchbase